Since it was founded, it has published over 30,000 scientific articles, which have allowed us to gain a better understanding of the main diseases in1
This discovery changes the view of the progression of leukaemia, opens the door to early diagnosis, and offers new treatment strategies.
In the next three years, the projects selected, led by Elías Campo, Patrícia Pérez Galán and Josep Dalmau, are aimed at studying how cancer cells mod1
An international study, published in Nature Genetics, identifies more than 100 new genes involved in the disease and defines new groups of patients w1
The partnership aims to improve current characterization and research practices of this disease.
A study led by researchers from the Hospital Clínic-IDIBAPS shows that a new treatment without chemotherapy is effective in treating indolent clinica1
The director of IDIBAPS won the award for his contribution to the study of lymphoid neoplasms.
This Wednesday, the Hospital Clínic de Barcelona held an event to show its gratitude for all the expressions of solidarity received since the start o1
The presentation took place on Monday 17 May 2021 at the Royal Palace of El Pardo, in Madrid, at an event presided over by the King and Queen of Spai1
Beà, a researcher of the IDIBAPS group Molecular pathology in lymphoid neoplasms, has authored 119 articles, 30 of them as the principal author, with1
